Adamax common uses, half-life, side effects and more
About
Adamax is a synthetic research peptide used as a nootropic for focus and mental energy. It is sold as a longer-acting version of Semax. Semax is a peptide derived from the hormone ACTH and used in Russia for cognition and recovery. Adamax adds chemical changes meant to help it last longer and reach the brain more easily. A small nootropics vendor created it and has since shut down. Even that maker said it was made with no research of any kind. It is not approved anywhere and is sold as an unregulated research chemical.
Common uses
- Focus and concentration
- Memory and learning support
- Mental energy and reduced fatigue
- Mood and motivation
- General neuroprotection
Frequency
Once daily in the morning
Dosing
Community reports cluster around 100 to 200 mcg once daily by nasal spray. Some users go up to about 300 mcg. Much higher figures circulating online come from automated dosing-guide sites rather than real users or the original maker. Some of those sites list several milligrams per dose. That is tens of times the community amount. It appears to confuse the 10 mg vial size with a single dose.
Half-life
The half-life of Adamax is estimated at about 21 minutes but nobody has measured it in people, animals, or a test tube. The figure comes from N-Acetyl Semax, which shares its acetyl cap and held steady for 15 minutes in rat plasma before breaking down at the parent's pace. Semax itself without those caps lasted only about 4 minutes in rats and blocking the enzymes that attack its two ends stops at most four fifths of its breakdown. Users still describe an effect that lasts 8 to 10 hours.
Side effects
- Headache reported by some users
- Trouble sleeping if taken later in the day
- Anxiety, restlessness, or feeling overstimulated
- Nasal irritation or burning from the spray
- A raised heart rate or blood pressure reported anecdotally
How it works
Adamax has no mechanism studies of its own. Everything here is inferred from related peptides. Its Semax core is thought to raise brain-derived neurotrophic factor and to nudge dopamine and serotonin signaling. The added adamantane cage is a standard chemistry trick for making a peptide more fat-soluble, more stable against breakdown, and better at crossing into the brain. The idea is that this makes Adamax last longer than plain Semax. None of this has been tested in Adamax itself. It remains an inference from the parent peptide rather than a measured fact.
Research quality
No study of Adamax exists in any species. There is no direct evidence for it. The parent peptide Semax is genuinely researched in Russian rodent and clinical work. The benefit and mechanism claims for Adamax are extrapolated from that work rather than measured. What is known about Adamax itself comes from vendor material and community reports. Those reports agree on how it is dosed and what it feels like but establish nothing about whether it works or is safe.
Warnings
- No safety data exists for Adamax in either humans or animals
- The supply is unregulated so purity, dose accuracy, and contamination cannot be verified
- Online dose figures disagree by more than tenfold because some sites mistake the 10 mg vial size for a single human dose
- Adamax is not approved for human use anywhere and should not be treated as a medicine
- Anecdotal reports include a raised heart rate and blood pressure so caution is sensible with heart conditions or other stimulants
- Anyone with a medical condition or taking other medications should talk to a clinician before using it
Sources (9)
-
Semax regulates BDNF and TrkB in the rat hippocampus (Dolotov et al.)
Brain Research 2006
-
Semax activates dopaminergic and serotonergic systems in rodents (Eremin et al.)
Neurochemical Research 2005
-
Adamantane-bearing neurotrophic peptides improve learning, neurogenesis and synaptic plasticity in mice (Li et al.)
FEBS Letters 2010 (PMID 20600002)
-
Community origin writeup recording the creator's statement of no research
nootropics community blog
-
Semax is degraded from the blood within minutes after intranasal dosing in rats (Shevchenko et al.)
Russian Journal of Bioorganic Chemistry 2006 (PMID 16523722)
-
Degradation of ACTH/MSH(4-10) and its synthetic analog Semax by rat serum enzymes, in which blocking the enzymes that attack the two ends stopped most of the breakdown
Peptides 1993 (PMID 8392718)
-
Patent on the adamantane-bearing peptide P21, with a test tube stability result in human plasma and levels in mice at 10 and 30 minutes after a dose
US Patent 9,327,011
-
European product information for the afamelanotide implant, giving a half-life of approximately 30 minutes
European Medicines Agency product information for SCENESSE
-
Plasma half-life of the parent hormone alpha-MSH measured in four men
Psychopharmacology 1977;55(2):165-72 (PMID 23563)